NINJ2 and lung carcinoma: NINJ2 (rs75750647 and rs10849390) increased the risk of lung cancer in people aged ≤59 years, while NINJ2 rs11610368 was correlated with a reduced risk of lung cancer in people aged >59 years, non-drinkers, and non-smokers.